Comments
Loading...

Biohaven Analyst Ratings

BHVNNYSE
Logo brought to you by Benzinga Data
Consensus Rating1
Buy
Highest Price Target1
$148.50
Lowest Price Target1
$21.00
Consensus Price Target1
$61.16

Biohaven Analyst Ratings and Price Targets | NYSE:BHVN | Benzinga

Biohaven Ltd has a consensus price target of $61.16 based on the ratings of 17 analysts. The high is $148.5 issued by Wedbush on August 8, 2022. The low is $21 issued by RBC Capital on May 19, 2025. The 3 most-recent analyst ratings were released by RBC Capital, RBC Capital, and Baird on May 19, 2025, May 13, 2025, and April 28, 2025, respectively. With an average price target of $44 between RBC Capital, RBC Capital, and Baird, there's an implied 178.17% upside for Biohaven Ltd from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Feb
4
Mar
1
Apr
1
May
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

RBC Capital
Baird
Morgan Stanley
JP Morgan
HC Wainwright & Co.

1calculated from analyst ratings

Analyst Ratings for Biohaven

Buy NowGet Alert
05/19/2025Buy Now32.76%RBC Capital
Leonid Timashev37%
$54 → $21DowngradeOutperform → Sector PerformGet Alert
05/13/2025Buy Now241.39%RBC Capital
Leonid Timashev37%
$61 → $54MaintainsOutperformGet Alert
04/28/2025Buy Now260.35%Baird
Brian Skorney57%
$60 → $57MaintainsOutperformGet Alert
03/07/2025Buy Now298.29%Morgan Stanley
Terence Flynn64%
$69 → $63MaintainsOverweightGet Alert
03/05/2025Buy Now329.9%JP Morgan
Tessa Romero56%
$72 → $68MaintainsOverweightGet Alert
03/04/2025Buy Now241.39%HC Wainwright & Co.
Douglas Tsao50%
$54 → $54ReiteratesBuy → BuyGet Alert
03/04/2025Buy Now285.64%RBC Capital
Leonid Timashev37%
$61 → $61ReiteratesOutperform → OutperformGet Alert
02/11/2025Buy Now310.93%Deutsche Bank
David Hoang39%
→ $65Initiates → BuyGet Alert
12/17/2024Buy NowCantor Fitzgerald
Charles Duncan68%
ReiteratesOverweight → OverweightGet Alert
12/17/2024Buy Now273%HC Wainwright & Co.
Douglas Tsao50%
$59 → $59ReiteratesBuy → BuyGet Alert
12/04/2024Buy Now285.64%RBC Capital
Leonid Timashev37%
$58 → $61ReiteratesOutperform → OutperformGet Alert
11/26/2024Buy Now273%HC Wainwright & Co.
Douglas Tsao50%
$59 → $59ReiteratesBuy → BuyGet Alert
11/25/2024Buy Now266.68%RBC Capital
Leonid Timashev37%
$66 → $58MaintainsOutperformGet Alert
11/14/2024Buy Now273%HC Wainwright & Co.
Douglas Tsao50%
$59 → $59ReiteratesBuy → BuyGet Alert
11/13/2024Buy Now374.15%TD Cowen
Tyler Van Buren45%
$55 → $75MaintainsBuyGet Alert
11/13/2024Buy Now317.25%RBC Capital
Leonid Timashev37%
$68 → $66MaintainsOutperformGet Alert
10/23/2024Buy NowCantor Fitzgerald
Charles Duncan68%
Reiterates → OverweightGet Alert
10/04/2024Buy NowCantor Fitzgerald
Charles Duncan68%
Reiterates → OverweightGet Alert
10/03/2024Buy Now329.9%JP Morgan
Tessa Romero56%
$55 → $68MaintainsOverweightGet Alert
09/24/2024Buy Now317.25%Bernstein
William Pickering38%
$55 → $66MaintainsOutperformGet Alert
09/24/2024Buy Now291.96%B of A Securities
Jason Gerberry59%
$52 → $62MaintainsBuyGet Alert
09/24/2024Buy Now329.9%RBC Capital
Leonid Timashev37%
$59 → $68MaintainsOutperformGet Alert
09/24/2024Buy NowCantor Fitzgerald
Charles Duncan68%
Reiterates → OverweightGet Alert
09/24/2024Buy Now273%HC Wainwright & Co.
Douglas Tsao50%
$59 → $59ReiteratesBuy → BuyGet Alert
09/23/2024Buy Now279.32%Leerink Partners
Marc Goodman72%
$55 → $60MaintainsOutperformGet Alert
09/23/2024Buy Now380.47%Piper Sandler
Christopher Raymond54%
$66 → $76MaintainsOverweightGet Alert
09/23/2024Buy Now279.32%Baird
Brian Skorney57%
$58 → $60MaintainsOutperformGet Alert
09/16/2024Buy Now260.35%Jefferies
Amy Li2%
→ $57Initiates → BuyGet Alert
09/04/2024Buy Now247.71%Bernstein
William Pickering38%
→ $55Initiates → OutperformGet Alert
09/04/2024Buy Now273%RBC Capital
Leonid Timashev37%
$59 → $59ReiteratesOutperform → OutperformGet Alert
08/19/2024Buy NowCantor Fitzgerald
Charles Duncan68%
Reiterates → OverweightGet Alert
08/13/2024Buy Now241.39%UBS
Ashwani Verma46%
$55 → $54MaintainsBuyGet Alert
08/12/2024Buy NowCantor Fitzgerald
Charles Duncan68%
Reiterates → OverweightGet Alert
07/24/2024Buy Now266.68%Morgan Stanley
Terence Flynn64%
→ $58Initiates → OverweightGet Alert
06/18/2024Buy Now273%RBC Capital
Leonid Timashev37%
$59 → $59ReiteratesOutperform → OutperformGet Alert
05/30/2024Buy Now273%HC Wainwright & Co.
Douglas Tsao50%
$59 → $59ReiteratesBuy → BuyGet Alert
05/30/2024Buy NowCantor Fitzgerald
Charles Duncan68%
Reiterates → OverweightGet Alert
05/13/2024Buy Now273%HC Wainwright & Co.
Douglas Tsao50%
$63 → $59MaintainsBuyGet Alert
04/23/2024Buy Now279.32%UBS
Ashwani Verma46%
$59 → $60MaintainsBuyGet Alert
04/18/2024Buy NowCantor Fitzgerald
Charles Duncan68%
Reiterates → OverweightGet Alert
04/10/2024Buy NowCantor Fitzgerald
Charles Duncan68%
Reiterates → OverweightGet Alert
04/09/2024Buy Now285.64%RBC Capital
Leonid Timashev37%
$61 → $61ReiteratesOutperform → OutperformGet Alert
03/04/2024Buy Now298.29%HC Wainwright & Co.
Douglas Tsao50%
$50 → $63MaintainsBuyGet Alert
03/01/2024Buy Now285.64%RBC Capital
Leonid Timashev37%
$62 → $61MaintainsOutperformGet Alert
03/01/2024Buy Now247.71%TD Cowen
Tyler Van Buren45%
$35 → $55MaintainsOutperformGet Alert
02/23/2024Buy Now254.03%JP Morgan
Tessa Romero56%
$32 → $56MaintainsOverweightGet Alert
02/16/2024Buy Now291.96%RBC Capital
Leonid Timashev37%
→ $62Initiates → OutperformGet Alert
02/06/2024Buy Now273%UBS
Ashwani Verma46%
→ $59Initiates → BuyGet Alert
12/22/2023Buy Now216.1%HC Wainwright & Co.
Douglas Tsao50%
→ $50Initiates → BuyGet Alert
12/08/2023Buy Now266.68%Baird
Brian Skorney57%
→ $58Initiates → OutperformGet Alert
11/20/2023Buy Now102.3%JP Morgan
Tessa Romero56%
$26 → $32MaintainsOverweightGet Alert
11/15/2023Buy Now127.59%Piper Sandler
Christopher Raymond54%
$29 → $36MaintainsOverweightGet Alert
08/16/2023Buy Now51.73%JP Morgan
Tessa Romero56%
$27 → $24MaintainsOverweightGet Alert
07/17/2023Buy Now95.98%Cantor Fitzgerald
Charles Duncan68%
→ $31ReiteratesOverweight → OverweightGet Alert
06/06/2023Buy Now77.02%BTIG
Thomas Shrader39%
$24 → $28Reiterates → BuyGet Alert
04/04/2023Buy Now95.98%Cantor Fitzgerald
Charles Duncan68%
$27 → $31MaintainsOverweightGet Alert
01/24/2023Buy Now51.73%SVB Leerink
Marc Goodman72%
→ $24Initiates → OutperformGet Alert
01/04/2023Buy Now45.41%JP Morgan
Tessa Romero56%
→ $23Initiates → OverweightGet Alert
12/02/2022Buy Now51.73%BTIG
Thomas Shrader39%
→ $24Initiates → BuyGet Alert
10/26/2022Buy Now32.76%Piper Sandler
Christopher Raymond54%
$23 → $21MaintainsOverweightGet Alert
10/12/2022Buy Now45.41%Piper Sandler
Christopher Raymond54%
→ $23Initiates → OverweightGet Alert
08/19/2022Buy NowPiper Sandler
Christopher Raymond54%
DowngradeOverweight → NeutralGet Alert
08/08/2022Buy Now838.82%Wedbush
Laura Chico46%
→ $148.5DowngradeOutperform → NeutralGet Alert

FAQ

Q

What is the target price for Biohaven (BHVN) stock?

A

The latest price target for Biohaven (NYSE:BHVN) was reported by RBC Capital on May 19, 2025. The analyst firm set a price target for $21.00 expecting BHVN to rise to within 12 months (a possible 32.76% upside). 37 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Biohaven (BHVN)?

A

The latest analyst rating for Biohaven (NYSE:BHVN) was provided by RBC Capital, and Biohaven downgraded their sector perform rating.

Q

When was the last upgrade for Biohaven (BHVN)?

A

There is no last upgrade for Biohaven

Q

When was the last downgrade for Biohaven (BHVN)?

A

The last downgrade for Biohaven Ltd happened on May 19, 2025 when RBC Capital changed their price target from $54 to $21 for Biohaven Ltd.

Q

When is the next analyst rating going to be posted or updated for Biohaven (BHVN)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Biohaven, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Biohaven was filed on May 19, 2025 so you should expect the next rating to be made available sometime around May 19, 2026.

Q

Is the Analyst Rating Biohaven (BHVN) correct?

A

While ratings are subjective and will change, the latest Biohaven (BHVN) rating was a downgraded with a price target of $54.00 to $21.00. The current price Biohaven (BHVN) is trading at is $15.82, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch